Total Return tumbles back to just 61% overall

Covid Vaccine Stocks slip back to lowest point - a return of just 61% overall for all stocks. Every stock in the index lost ground this week except Immunity Bio.

 

Broad-based sell-off to end the week - 24 stocks dropped.

Another broad-based sell-off with 24 stocks dropping and only three gaining.

The overall average was a significant loss of 3.2%.

The biggest loser was Generex falling 20%. Tonix dropped 8% and PDS dropped 7%. 

 

Unanimous Sell-off Down 5.5% on average overall

Devastating Unanimous Sell-OFF!! 

5.5% LOSS OVERALL. 

 

Big broad-based gains for Covid Vaccine Stocks - Immunity Bio jumps 22%

Rocketing upwards on February 15. A real strong broad-based move upwards lead by Immunity Bio which moved up 22%. There were fully 24 winners and only three losers today. 

The next strongest gainers were Novavax and Vaxart with 9% gains.

Vir, Ocugen and VBI all picked up 7%. 

 

Heavy selling to start the week - Big Three hit hard.

 

Heavy selling to start the week. Overall there was a loss of 3.5%. There were 22 stocks who lost ground and five that gained.

The big three took the biggest hit. Moderna fell just under 12%, Novavax fell 11% and BioNTech fell 10%. Arcturus fell 7%. 

CureVac, Vir, Sorrento and Tonix fell 6%. 

OncoSec and iBio picked up 5%. 

Covid Vaccine Stocks move moderately higher.

Covid Vaccine Stocks bounce off the lows of January with total returns edging up to 72%.

PDS jumps by 117% in total returns and into third spot.

 

Week finishes with a 2.3% drop

Stocks close the week slipping another 2.3%. There were no double digit losses but only six that gained ground with 21 losers.

Adaptive lead on the downside with a loss of 8%. Inovio lost 6%. Emergent lead on the upside with a gain of 5%.

 

Small loss of 1.8% overall - Novavax stumbles 12%

Stocks edged downward, falling 1.8% overall with 17 losers and nine winners.

Novavax lead on the way down with a 12%. BioNTech fell 7% and TNXP fell 6%.

IMV lead on the upside picking up just under 5%.

 

Generex jumps by one half

Generex delivers one of the biggest gains in the Covid era with a 51% leap. 

This outsized gain generated a 3.6% overall gain. There were 22 winners today and five losers.

IMV picked up just under 8%, and Novavax is nearing a breakthrough of $100, closing at $94.80 after gaining 6%. 

 

Moderate move up with a 1.9% gain - 22 stocks gain and 5 lose.

That makes two positive days in a row. Today it was a gain of 1.9% on average overall.

IMV lead the way up with a double digit gain with a 10% pick up.

PDS picked up 6% whilte iBio, Inovio and Adaptive all picked up 5%.

 

Moderately hard move to the downside - 3.4% Loss

Another quite hard blow with 3.4% loss overall. 

There were no double digit losses but fully 12 stocks dropped 5% or more.

Only Generex and Vir gained with the other 25 losing ground.

iBio continued its down hill slalom leading the way down the hill, losing 7%. PDS dropped just under 7%. 

CureVac seems to be headed to 0 with another 6% loss. Immunity Bio, IMV and Inovio all lost over 6%. 

 

Blood-letting resumes after brief reprieve

After a reprieve of a few days and a couple really good days, the blood-letting resumed this Ground Hog Day.....

The overall average was a loss of 3.8%, notwithstanding and amazing gain by the seriously lagging Generex which picked up almost 16% today. 

There were no double digit losses, but a ton of big single digit losses, lead by VBI, Sorrento, Heat Bio and Inovio, all with losses of over 7%. 

 

Modest move upwards with a gain of 1.9% overall. Ocugen up 9%.

A modestly positive day with a gain of 1.9% overall. 21 stocks gained ground with 5 losing.

The biggest gainer was Ocugen with a pick up of 9%. The biggest loser was IBio with a loss of just over 5%.